Interferon beta in relapsing-remitting multiple sclerosis: an eight years experience in a specialist multiple sclerosis centre.

作者信息

Goodin D S

出版信息

J Neurol. 2006 Jul;253(7):947-8; author reply 949. doi: 10.1007/s00415-006-0097-z. Epub 2006 Jul 17.

DOI:10.1007/s00415-006-0097-z

PMID:16845567

Abstract

摘要

相似文献

Interferon beta in relapsing-remitting multiple sclerosis: an eight years experience in a specialist multiple sclerosis centre.

J Neurol. 2006 Jul;253(7):947-8; author reply 949. doi: 10.1007/s00415-006-0097-z. Epub 2006 Jul 17.

Interferon-beta treatment and the natural history of relapsing-remitting multiple sclerosis.

Ann Neurol. 2008 Jan;63(1):125-6; author reply 126-7. doi: 10.1002/ana.21185.

Interferons in relapsing remitting multiple sclerosis.

Lancet. 2003 May 24;361(9371):1824; author reply 1824-5. doi: 10.1016/S0140-6736(03)13421-6.

Interferons in relapsing remitting multiple sclerosis.

Lancet. 2003 May 24;361(9371):1821; author reply 1823-4. doi: 10.1016/S0140-6736(03)13416-2.

Interferons in relapsing remitting multiple sclerosis.

Lancet. 2003 May 24;361(9371):1821-2; author reply 1823-4. doi: 10.1016/S0140-6736(03)13417-4.

Interferons in relapsing remitting multiple sclerosis.

Lancet. 2003 May 24;361(9371):1822; author reply 1823-4. doi: 10.1016/S0140-6736(03)13418-6.

NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.

Lancet Neurol. 2009 Jun;8(6):519-29. doi: 10.1016/S1474-4422(09)70085-7. Epub 2009 May 4.

Interferon beta in relapsing-remitting multiple sclerosis. An eight years experience in a specialist multiple sclerosis centre.

J Neurol. 2005 Jul;252(7):795-800. doi: 10.1007/s00415-005-0748-5. Epub 2005 Mar 18.

Interferon antibodies: do they alter the beneficial effects of beta-interferon upon relapse rate in multiple sclerosis?

Mult Scler. 2004 Apr;10(2):123-5. doi: 10.1191/1352458504ms1017ed.

A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.

Neurology. 2006 Oct 10;67(7):1313-4. doi: 10.1212/01.wnl.0000243810.20687.51.

本文引用的文献

Interferon beta in relapsing-remitting multiple sclerosis. An eight years experience in a specialist multiple sclerosis centre.

J Neurol. 2005 Jul;252(7):795-800. doi: 10.1007/s00415-005-0748-5. Epub 2005 Mar 18.

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.

Neurology. 2004 Nov 23;63(10):1788-95. doi: 10.1212/01.wnl.0000146958.77317.3e.

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial.

Neurology. 2002 Nov 26;59(10):1496-506. doi: 10.1212/01.wnl.0000034080.43681.da.

Randomized trials or observational tribulations?

N Engl J Med. 2000 Jun 22;342(25):1907-9. doi: 10.1056/NEJM200006223422511.

Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.

Lancet. 1998 Nov 7;352(9139):1491-7.

Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.

Neurology. 1995 Jul;45(7):1277-85.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验